Vaccine testing expertise

Leverage decades of scientific experience in vaccine development with comprehensive testing solutions that support safety, immunogenicity, efficacy, and biomarker assessment across all phases of clinical development.

immunogenicity-immune-response

Immunogenicity & immune response

  • Assays to characterize humoral and cellular immune responses

  • Detection of anti-drug antibodies (ADAs)

  • Neutralizing antibody (NAb) assays to assess impact on PK, PD, safety, and efficacy

  • CD4/CD8 quantitation, B-cell response, cytokine release, and activation assays

  • ELISpot and flow cytometry for cellular immunity

Molecular & virology testing

  • qPCR assays for viral detection and quantification

  • Discrimination assays to differentiate wild-type virus from vaccine strains

  • Custom biodistribution and viral shedding assays for transmission risk assessment

Learn more

molecular-virology-testing
assay-development-validation

Assay development & validation

  • Fit-for-purpose assay development and transfer

  • Immunoassays: ELISA, Luminex®, MSD®

  • Molecular platforms: qPCR, RT-qPCR, ddPCR, NGS

Learn more

Vaccine trial experience

Proven expertise across multiple vaccine programs, including SARS-CoV-2, Influenza, RSV, HPV, EBV, CMV, Zika, Chikungunya, Dengue, and more.

Eurofins Viracor BioPharma supported assay development, validation, and testing for the Moderna mRNA-1273 COVID-19 vaccine clinical trial, including RT-qPCR and sequencing assays.

Learn more

vaccine-experience-1

5 potential pitfalls to avoid for successful vaccine trials

Vaccine clinical trials present unique challenges. In this video, Eurofins Viracor BioPharma experts highlight five common pitfalls and practical strategies to help streamline studies and achieve more reliable outcomes.